PARICALCITOL solution for injection

PARICALCITOL solution for injection
Product Description

Strength: 2 mcg/ml; 5 mcg/ml Presentation: ampoules, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml); vials, 1 ml (2 mcg/ml & 5 mcg/ml) & 2 ml (5 mcg/ml) Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott)

Read more Show less

Rafarm S.A

  • GR
  • 2015
    On CPHI since
View company profile

Rafarm S.A

  • GR
  • 2015
    On CPHI since
View company profile

More Products from Rafarm S.A (38)

  • LEVOCARNITINE solution for injection

    Product LEVOCARNITINE solution for injection

    Strength: 1 g/5 ml; 2 g/5 ml Presentation: ampoules, 5 ml Therapeutic area: Carnitine Deficiency Innovator: Carnitor (Sigma-Tau)
  • LEVOFLOXACIN eye drops solution

    Product LEVOFLOXACIN eye drops solution

    Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen)
  • LEVOFLOXACIN PRESERVATIVE FREE eye drops solution

    Product LEVOFLOXACIN PRESERVATIVE FREE eye drops solution

    Strength: 5 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial external ocular infections Innovator: Oftaquix (Santen)
  • OLOPATADINE eye drops solution

    Product OLOPATADINE eye drops solution

    Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Allergic Conjunctivitis Innovator: Opatanol (Alcon)
  • PALONOSETRON solution for injection

    Product PALONOSETRON solution for injection

    Strength: 250 mcg/5ml Presentation: vials, 5 ml Therapeutic area: Acute Nausea & Vomiting Innovator: Aloxi (Helsinn Birex)
  • PARICALCITOL soft gel capsules

    Product PARICALCITOL soft gel capsules

    Strength: 1 mcg/cap; 2 mcg/cap; 4 mcg/cap Therapeutic area: Secondary Hyperparathyroidism Innovator: Zemplar (Abbott)
  • PRAMIPEXOLE tablets

    Product PRAMIPEXOLE tablets

    Strength: 0.088 mg/tab; 0.18 mg/tab; 0.35 mg/tab; 0.7 mg/tab Therapeutic area: Idiopathic Parkinson's Disease & Idiopathic restless legs syndrome Innovator: Mirapexin (Boehringer Ingelheim)
  • SODIUM CROMOGLICATE PRESERVATIVE FREE eye drops solution

    Product SODIUM CROMOGLICATE PRESERVATIVE FREE eye drops solution

    Strength: 20 mg/ml Presentation: vials, 5 ml & 10 ml Therapeutic area: Relief and treatment of seasonal and perennial allergic conjunctivitis Innovator: Opticrom (Sanofi)
  • TOBRAMYCIN + DEXAMETHASONE eye drops suspension

    Product TOBRAMYCIN + DEXAMETHASONE eye drops suspension

    Strength: (3 mg+1 mg)/ml Presentation: vials, 5 ml Therapeutic area: Intraocular inflammation & ocular surface bacterial contamination Innovator: Tobradex (Alcon-Novartis)
  • TRAVOPROST + TIMOLOL eye drops solution

    Product TRAVOPROST + TIMOLOL eye drops solution

    Strength: (40 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: DuoTrav (Alcon-Novartis)
  • TRAVOPROST eye drops solution

    Product TRAVOPROST eye drops solution

    Strength: 40 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Travatan (Alcon-Novartis)
  • ZOLEDRONIC ACID concentrate solution for infusion

    Product ZOLEDRONIC ACID concentrate solution for infusion

    Strength: 4 mg/5 ml Presentation: vials, 5 ml Therapeutic area: Skeletal Related Events in Advanced Malignancies & Tumour-Induced Hypercalcaemia Innovator: Zometa (Novartis)
show all 38 other products